Caregiver support is becoming part of the Alzheimer's policy frame

The clinical and regulatory conversation about Alzheimer's has been dominated for two years by anti-amyloid therapy. The payment-policy conversation outside that frame is starting to catch up.

The most concrete near-term lever is the CMS GUIDE Model - a payment model that supports comprehensive dementia care, care coordination, 24/7 caregiver support, and respite services for traditional Medicare beneficiaries with dementia. For a plain-language overview, see our explainer on what the CMS GUIDE Model is. The model is operating at participating sites and the early evaluation work is underway. Adjacent state-level policy changes - paid family leave expansion, caregiver tax credit proposals, Medicaid waiver design - are visible in multiple states.

Two structural facts shape why this matters:

• The unpaid caregiving labor of family members has historically been the largest cost category in dementia care. Treating it as a system-level input rather than an externality changes how the math works.
• Disease-modifying therapy does not eliminate the caregiving load. It modifies the trajectory. Even on optimistic assumptions, the caregiving frame is still load-bearing for the patient population.

What we are watching: published evaluations of GUIDE Model effects on caregiver burden and patient outcomes; whether commercial payers and Medicare Advantage plans take up similar care-coordination structures; and whether the policy momentum survives into the next budget cycle.

The signal is that the operational system around dementia care - not just the drug - is becoming a real subject of policy. For a reference layout of what currently exists across federal, state, employer, and direct-support programs, see our snapshot of the caregiver support landscape.